Recellularization is a transformative process in tissue engineering that involves repopulating a decellularized tissue scaffold with living cells to restore its structure and function. Decellularization is the initial step, where cells are removed from a tissue or organ, leaving behind a three-dimensional extracellular matrix. This acellular matrix retains the tissue's architecture, mechanical properties, and signaling cues. Recellularization follows, where the acellular scaffold is infused with the desired cell types, such as stem cells or differentiated cells, allowing them to adhere, proliferate, and differentiate within the matrix. The goal is to create functional, bioengineered tissues that closely mimic native structures. Recellularization has been applied to various organs, including the heart, lungs, liver, and kidneys, offering potential solutions for organ transplantation shortages. This technique is not only a means to generate replacement organs but also serves as a valuable tool for drug testing, disease modeling, and understanding cell-matrix interactions. Challenges in achieving optimal recellularization include maintaining cell viability, promoting proper tissue integration, and ensuring appropriate functionality. Ongoing research continues to refine recellularization techniques, addressing these challenges and unlocking the full potential of this innovative approach in regenerative medicine.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy